Papadimitriou Nikos, Kazmi Nabila, Tsilidis Konstantinos K, Richmond Rebecca C, Lynch Brigid M, Bendinelli Benedetta, Ricceri Fulvio, Sánchez Maria-Jose, Trobajo-Sanmartín Camino, Jakszyn Paula, Simeon Vittorio, Severi Gianluca, Perduca Vittorio, Truong Therese, Ferrari Pietro, Keski-Rahkonen Pekka, Weiderpass Elisabete, Eichelmann Fabian, Schulze Matthias B, Katzke Verena, Fortner Renée Turzanski, Heath Alicia K, Aune Dagfinn, Harewood Rhea, Dahm Christina C, Llorente Adrian, Gunter Marc J, Murphy Neil, Lewis Sarah J
Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Cancer Epidemiol Biomarkers Prev. 2025 Apr 3;34(4):578-587. doi: 10.1158/1055-9965.EPI-24-1390.
Current evidence suggests higher physical activity (PA) levels are associated with a reduced risk of colorectal cancer. However, the mediating role of the circulating metabolome in this relationship remains unclear.
Targeted metabolomics data from 6,055 participants in the European Prospective Investigation into Cancer and Nutrition cohort were used to identify metabolites associated with PA and derive a metabolomic signature of PA levels. PA levels were estimated using the validated Cambridge PA index based on baseline questionnaires. Mediation analyses were conducted in a nested case-control study (1,585 cases, 1,585 controls) to examine whether individual metabolites and the metabolomic signature mediated the PA-colorectal cancer association.
PA was inversely associated with colorectal cancer risk (OR per category change: 0.90, 95% confidence interval, 0.83-0.97; P value = 0.009). PA levels were associated with 24 circulating metabolites after FDR correction, with the strongest associations observed for phosphatidylcholine acyl-alkyl (PC ae) C34:3 (FDR-adjusted P value = 1.18 × 10-10) and lysophosphatidylcholine acyl C18:2 (FDR-adjusted P value = 1.35 × 10-6). PC ae C34:3 partially mediated the PA-colorectal cancer association (natural indirect effect: 0.991, 95% confidence interval, 0.982-0.999; P value = 0.04), explaining 7.4% of the association. No mediation effects were observed for the remaining metabolites or the overall PA metabolite signature.
PC ae C34:3 mediates part of the PA-colorectal cancer inverse association, but further studies with improved PA measures and extended metabolomic panels are needed.
These findings provide insights into PA-related biological mechanisms influencing colorectal cancer risk and suggest potential targets for cancer prevention interventions.
目前的证据表明,较高的身体活动(PA)水平与降低结直肠癌风险相关。然而,循环代谢组在这种关系中的中介作用仍不清楚。
利用欧洲癌症与营养前瞻性调查队列中6055名参与者的靶向代谢组学数据,识别与PA相关的代谢物,并得出PA水平的代谢组学特征。PA水平通过基于基线问卷的经过验证的剑桥PA指数进行估计。在一项巢式病例对照研究(1585例病例,1585例对照)中进行中介分析,以检查个体代谢物和代谢组学特征是否介导了PA与结直肠癌的关联。
PA与结直肠癌风险呈负相关(每类别变化的OR:0.90,95%置信区间,0.83 - 0.97;P值 = 0.009)。经FDR校正后,PA水平与24种循环代谢物相关,其中磷脂酰胆碱酰基 - 烷基(PC ae)C34:3(FDR调整后的P值 = 1.18 × 10 - 10)和溶血磷脂酰胆碱酰基C18:2(FDR调整后的P值 = 1.35 × 10 - 6)的相关性最强。PC ae C34:3部分介导了PA与结直肠癌的关联(自然间接效应:0.991,95%置信区间,0.982 - 0.999;P值 = 0.04),解释了该关联的7.4%。其余代谢物或整体PA代谢物特征未观察到中介效应。
PC ae C34:3介导了PA与结直肠癌负相关的部分作用,但需要采用改进的PA测量方法和扩展的代谢组学面板进行进一步研究。
这些发现为影响结直肠癌风险的PA相关生物学机制提供了见解,并为癌症预防干预提出了潜在靶点。